EMOPT team

Evaluation Modeling Optimization of Pharmacological and Therapeutic interventions Research team from university of Saint Etienne.

[ollier edouard @EdouardOllier]

Audrick Gibert was also presenting his work on the PK/PD of unfractionated heparin during cardio pulmonary by-pass !

@Sainbiose_Lab @ChuSaintEtienne

[ollier edouard @EdouardOllier]

Great talk of Robin Chaux at the 2023 PAGE meeting on new methodological approach for meta analysis of population PK model !

@Sainbiose_Lab @ChuSaintEtienne

[Reviewer Number 3 @thirdreviewer]

the middle author on your three-author paper

[ESA Webb Telescope @ESA_Webb]

The dawn of a new era in astronomy has begun as the world gets its first look at the full capabilities of the NASA/ESA/CSA James Webb Space Telescope. The telescope’s first full-colour images & spectroscopic data were released today. Read more here https://t.co/kdD6ew5306 or👇

[EMOPT team @EMOPT42]

@L_Aulin @page_meeting @Chaux_Robin voilà ton objectif pour 2023 !

[EMOPT team @EMOPT42]

@Univ_St_Etienne @saib_sonia !!! Well done !!!

[Université Jean Monnet Saint-Étienne @Univ_St_Etienne]

📣 Doctorants #UJM, vous êtes invités à participer à la première journée des doctorants du Campus Santé Innovations afin de découvrir les travaux de recherche des équipes présentes sur le campus.
🗓 : Jeudi 30 juin, de 9h30 à 16h
➡ : Programme sur votre portail MyUJM

[Sonia Saib @saib_sonia]

Nouvelle publication pour l'équipe @EMOPT42 !

Bonne lecture

TNF-α and IL-1β Exposure Modulates the Expression and Functionality of P-Glycoprotein in Intestinal and Renal Barri… https://t.co/kin8Wc7uLz

[EMOPT team @EMOPT42]

Posters ready pour la première journée des doctorants du Campus Santé Innovations #UJM ! Au programme modélisation, IA et données in-vitro !
@ChuSaintEtienne @Univ_St_Etienne @SoniaSaib @Chaux_Robin

[Maarten van Smeden @MaartenvSmeden]

Periodic reminder that for most statistical tests: It’s Just A Linear Model #IJALM

[EMOPT team @EMOPT42]

Pour clôturer la session, Audrick Gibert nous présente son travail sur l’individualisation du facteur VIII dans l’hémophilie ! #SFPT2022

[EMOPT team @EMOPT42]

Au tour de Robin Chaux de présenter ses travaux sur l’individualisation en temps réel de l’héparine au congrès de la SFPT @SFPT_fr !
@Univ_St_Etienne @MedvascC @ChuSaintEtienne

[EMOPT team @EMOPT42]

Lancement du congrès pour l’équipe @EMOPT42 avec Sonia Saïb pour le prix de thèse ! Au programme inflammation et modulation des transporteurs de médicaments @ChuSaintEtienne @Univ_St_Etienne @MedvascC

[Soc. Française de Pharmacologie et Thérapeutique @SFPT_fr]

C'est parti pour #SFPT2022 à Lille 👨‍🎓👩‍🎓

[Laurent Bertoletti @LaurentBertole1]

👏@LudoLafaie for highlighting the challenge of AC therapy in elderly VTE patients
Teamwork from @EMOPT42 and @mmonrealriete, opened way for the individualization of TTT

The impact of advanced age on anticoagulant therapy for acute venous thromboembolism https://t.co/RAih9aL6n4

[MedVasc&Therapeutique_CHUSE @MedvascC]

Bravo @LudoLafaie, ancien interne de notre service de Médecine Vasculaire et Thérapeutique 👍

[EMOPT team @EMOPT42]

You have a patient treated with apixaban who needs an invasive procedure ?

You need to estimate the time to reach apixaban concentrations below the threshold of 30 ng/ml ?

Read this new paper of our 1st year PhD student !

@INNOVTE1 @MedvascC

https://t.co/Z3FbeVezNJ

[Laurent Bertoletti @LaurentBertole1]

#DDI risk assessment is recommended to decide the treatment of #cancer-associated #thrombosis.
But few specific data are available.

Congrats to @LudoLafaie and our @Inserm #SAINBIOSE team for this in-vitro study of DDI risk beetween #TKI and #DOAC

https://t.co/1CN6fNJHDv

[EMOPT team @EMOPT42]

New Paper from the team !

Robust real time optimization of unfractionated heparin (UFH) during cardiopulmonary bypass

@EdouardOllier @ChuSaintEtienne

https://t.co/lp5AQjORlN

[Stefan Michiels @StefanMichiels]

Paper #2 IPD-NMA: for complex network meta-analyses of clinical trials with time-to-event outcomes using individual data we go for a nice penalised approach (with treatment modifiers and nonproportionality) @Cesp_Inserm @EdouardOllier @GustaveRoussy : https://t.co/mHoMVu5N4Y